Consolidated Condensed Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 27, 2020	Mar. 29, 2019
Sales	$ 1,713.5	$ 1,592.9
Cost of sales	(837.7)	(780.2)
Gross profit	875.8	812.7
Operating costs:
Selling, general and administrative expenses	(557.2)	(486.4)
Research and development expenses	(113.7)	(109.0)
Impairment of goodwill	(85.3)	0.0
Operating profit	119.6	217.3
Non-operating expenses, net:
Interest expense, net	(43.6)	(25.3)
Other non-operating expenses, net	(4.6)	0.4
Earnings from continuing operations before income taxes	71.4	192.4
Income taxes	(29.1)	(28.4)
Net earnings from continuing operations	42.3	164.0
Earnings (loss) from discontinued operations, net of income taxes	(0.4)	0.4
Net earnings	41.9	164.4
Mandatory convertible preferred dividends	(17.3)	(17.3)
Net earnings attributable to common stockholders	$ 24.6	$ 147.1
Net earnings per common share from continuing operations:
Net earnings per common share from continuing operations - basic (in dollars per share)	$ 0.07	$ 0.44
Net earnings per common share from continuing operations - diluted (in dollars per share)	0.07	0.43
Net earnings per share from discontinued operations:
Net earnings per share from discontinued operations - basic (in dollars per share)	0	0
Net earnings per share from discontinued operations - diluted (in dollars per share)	0	0
Net earnings per share:
Net earnings per share - Basic (in dollars per share)	0.07	0.44
Net earnings per share - Diluted (in dollars per share)	$ 0.07	$ 0.43
Average common stock and common equivalent shares outstanding:
Weighted average common shares outstanding used in basic earnings per share (in shares)	336.8	335.1
Weighted average common shares outstanding used in diluted earnings per share (in shares)	340.0	339.5
Products
Sales	$ 1,487.8	$ 1,405.1
Cost of sales	(692.5)	(647.9)
Services
Sales	225.7	187.8
Cost of sales	$ (145.2)	$ (132.3)